KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Change in Accured Expenses (2016 - 2025)

Fulgent Genetics' Change in Accured Expenses history spans 10 years, with the latest figure at $12.3 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 1862.58% year-over-year to $12.3 million; the TTM value through Dec 2025 reached $8.9 million, up 324.97%, while the annual FY2025 figure was $8.9 million, 324.97% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $12.3 million at Fulgent Genetics, up from -$1.1 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $20.0 million in Q2 2021 and bottomed at -$13.2 million in Q3 2022.
  • The 5-year median for Change in Accured Expenses is $225500.0 (2023), against an average of $491700.0.
  • The largest annual shift saw Change in Accured Expenses surged 4879.35% in 2021 before it tumbled 932.2% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$8.2 million in 2021, then skyrocketed by 124.35% to $2.0 million in 2022, then soared by 423.32% to $10.4 million in 2023, then crashed by 93.97% to $628000.0 in 2024, then soared by 1862.58% to $12.3 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Change in Accured Expenses are $12.3 million (Q4 2025), -$1.1 million (Q3 2025), and $5.2 million (Q2 2025).